Several chromosomal fusions, such as the MYB-NFIB fusion in adenoid cystic carcinoma, show dependence on IGF1R signaling, and IGF1R shows promise as a clinical target (Xie et al. 2015; Andersson et al. 2019). This evidence concerns the gene NFIB and adenoid cystic carcinoma.